Susquehanna International Group
OSIR

Susquehanna International Group’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Susquehanna International Group’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,700
Closed -$62K – 10911
2016
Q4 		$62K Buy
+12,700
New +$65K ﹤0.01% 9239
2016
Q2 		– Sell
-17,000
Closed -$97K – 10096
2016
Q1 		$97K Buy
+17,000
New +$119K ﹤0.01% 8448
2015
Q4 		– Sell
-10,800
Closed -$199K – 10639
2015
Q3 		$199K Buy
+10,800
New +$208K ﹤0.01% 8713
2015
Q2 		– Sell
-21,700
Closed -$381K – 10888
2015
Q1 		$381K Buy
21,700
+5,400
+33% +$90.7K ﹤0.01% 7588
2014
Q4 		$261K Sell
16,300
-28,200
-63% -$378K ﹤0.01% 8373
2014
Q3 		$560K Buy
44,500
+8,200
+23% +$117K ﹤0.01% 6999
2014
Q2 		$567K Sell
36,300
-22,700
-38% -$334K ﹤0.01% 7232
2014
Q1 		$775K Sell
59,000
-28,500
-33% -$446K ﹤0.01% 5974
2013
Q4 		$1.41M Buy
87,500
+300
+0.3% +$4.78K ﹤0.01% 4889
2013
Q3 		$1.45M Sell
87,200
-3,400
-4% -$50.3K ﹤0.01% 4664
2013
Q2 		$912K Buy
+90,600
New +$952K ﹤0.01% 5144

Other funds holding OSIR

FGAM
Financial Gravity Asset Management Lakeway, Texas $562M AUM

Susquehanna International Group's OSIR Position: Q2 2019 in Review

Susquehanna International Group sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 175,223 shares — an estimated $3.33M sold.

Susquehanna International Group first reported a position in OSIR in Q2 2013 and held it in 16 quarters. The position peaked at $3.65M in Q4 2014. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Susquehanna International Group reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Susquehanna International Group sold 175,223 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $3.33M.
  • Susquehanna International Group first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 16 quarters.
  • Susquehanna International Group's Osiris Therapeutics, Inc. Common Stock position peaked at $3.65M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.